Organization
Johns Hopkins Univ School of Medicine, Baltimore, United States of America
1 abstract
Abstract
BARICITINIB-ASSOCIATED CHANGES IN GLOBAL GENE EXPRESSION DURING A 24-WEEK PHASE 2 CLINICAL SLE TRIAL DESCRIBE A MECHANISM OF ACTION THROUGH INHIBITION OF JAK/STAT AND IFN RESPONSIVE GENE EXPRESSIONOrg: Charite Universitätsmedizin Berlin and Deutsches Rheumaforschungszentrum (DRFZ), Berlin, Germany, Univ of Occupational and Environmental Health, Kitakyushu, Japan, Johns Hopkins Univ School of Medicine, Baltimore, United States of America, Medical Univ of Vienna, Vienna, Austria, Eli Lilly and Company, Indianapolis, United States of America,